Delivery Order SPE2DB22D2206-SPE2DB25FHW52
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $7,030.77 for TEZSPIRE 210 mg/1.91 mL pen injectors, with a completion date of August 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $18,748.72 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for TEZSPIRE 210 mg/1.91 mL pen injectors, with a completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors valued at $4,687.18. This competitive award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $9,374.36 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors. This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a standard...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectables, with performance through August 15, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectors on May 2, 2025, with completion scheduled for May 23, 2025. This firm fixed-price, non-set-aside delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate...
- The Defense Logistics Agency (DLA) awarded a $23,435.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TEZSPIRE 210 mg/1.91 mL pen injectors, with performance expected to conclude by September 19, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical vendor within the federal medical supply chain. The company, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen injectors, with an ultimate completion date of August 14, 2025. This is a firm fixed price delivery order issued under a non-competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order valued at $11,717.95 to AmerisourceBergen Drug Corp for TEZSPIRE 210 mg/1.91 mL pen injections, with performance completion scheduled for July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors, valued at $2,343.59, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is performed from the company's corporate...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHW52Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,374.36 to AmerisourceBergen Drug Corp for TEZSPIRE 210 MG/1.91 ML pen injectors. This is a firm fixed price, competitively awarded order with no set-aside designation. The contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 through December 2026. Performance will be completed by August 4, 2025, and services will be executed from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. This delivery order represents pharmaceutical supply fulfillment for military healthcare operations through DLA's Medical Supply Chain. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected to supply TEZSPIRE, a specialty biologic medication, as part of its comprehensive role as a pharmaceutical prime vendor supporting Defense Health Agency, U.S. Coast Guard, and broader federal healthcare systems. The contract demonstrates the vendor's capability to meet federal medical procurement requirements through its established IDC vehicle, which enables flexible delivery of brand-name and generic pharmaceuticals, specialty medications, vaccines, and related medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 7/14/25 |